Striae distensae are atrophic dermal scars associated with psychosocial stress. Several treatments have been used but there is no gold standard until now. Fractional photothermolysis has been described as a successful and safe method to treat scars. In this description, we report 4 patients (Fitzpatrick phototype IV) who developed striae distensae after long-term use of topical corticosteroids and were successfully treated with fractional nonablative 1540 nm Erbium: glass laser.
1 August 2018 in Journal of the American Academy of Dermatology
BACKGROUND: The illegal practice of medicine in aesthetic procedures poses significant public health risks because of complications from unqualified individuals. Invasive treatments such as botulinum toxin and fillers are frequently performed by nonmedical professionals without proper medical training, resulting in infections, necrosis, and lasting sequelae. OBJECTIVE: This study aimed to analyze the complications from nonphysicians encountered by Brazilian specialists (dermatologists, plastic surgeons, and other specialists) in their clinical practice. MATERIALS AND METHODS: A multicenter survey involving 1,058 physicians (primarily dermatologists and plastic surgeons) across Brazil assessed complications from aesthetic procedures performed by nonmedical individuals. Descriptive statistics categorized complications by type and severity, identified responsible practitioners, and estimated the health care and economic burdens. RESULTS: Over half of the respondents treat more than 100 patients monthly, and 12.69% of patients had undergone procedures by nonmedical professionals. On average, five complications were treated monthly per physician; 17% led to permanent sequelae. Common issues included scarring (78.68%), inflammation (72.15%), and infection (65.43%). Most cases required up to 3 specialists and 7 to 8 consultations per year, often involving multiple surgeries. CONCLUSION: These findings underscore the urgent need for regulatory enforcement, public education, and legal protection. Brazil's experience may inform other countries confronting similar issues related to the unauthorized practice of aesthetic medicine.
25 January 2016 in Journal of Cosmetic and Laser Therapy
Silicone oil injections are often used for soft tissue augmentation and local and general adverse effects occurring from a few months to 15 years after injection have been reported. Here, we present a case of delayed granuloma formation due to liquid injectable silicone with large extent of involvement, which precluded surgical removal. Our patient was successfully treated with minocycline, considering its anti-inflammatory, immunomodulating and antigranulomatous properties. This case presents minocycline monotherapy as a useful treatment option for the management of severe granuloma induced by silicone use when surgical excision is not possible.
7 February 2024 in Journal of Cosmetic Dermatology
Background: Melasma is a chronic dermatosis that impacts the patient's quality of life and can present considerable challenges in terms of effective treatment. Objective: To evaluate the effectiveness, tolerability, and safety of 5% cysteamine combined with 4% nicotinamide in female subjects with melasma. Methods: This single‐center, single‐arm, prospective, open‐label study evaluated patients with melasma using a combination cream of 5% cysteamine and 4% nicotinamide in a progressive regimen (60 min in the first month, 120 min in the second month, and 180 min in the third month). Results: Overall, 35 treated subjects exhibited reduced modified Melasma Area and Severity Index (mMASI) ( p < 0.001) and decreased MelasQoL scores ( p < 0.001), accompanied by improved brightness, luminosity, homogeneity, and spot intensity ( p < 0.001). Photographic and colorimetric analysis revealed smaller spots and improved homogeneity. Limitations: Adherence to progressive daily treatment could not be evaluated long‐term. Conclusion: A combination cream comprising 5% cysteamine and 4% nicotinamide was effective, tolerable, and safe for treating melasma.